Xcout Intel
Scenic Biotech
Scenic Biotech is a biotechnology company headquartered in Amsterdam, Netherlands, that advances modifier therapy as an approach to treating genetic disorders by uncovering novel genome pathways.
Subscribe to see Scenic Biotech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Scenic Biotech at a glance
Scenic Biotech is a biotechnology company headquartered in Netherlands. Its most recent funding round, Series A, raised $31M in March 2022. Xcout tracks 13 named people at Scenic Biotech, including Oscar Izeboud (CEO).
Scenic Biotech leadership
- Oscar IzeboudCEO
- Alexander VosChairman of the Board
- Judith WalkerCMO
- Roland BürliCSO
- Sebastian NijmanFounder & Board Observer
- Thijn BrummelkampCo-founder
7 more named people on record for Scenic Biotech, with roles, board committees and tenure — see the full roster →
Scenic Biotech funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $31M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Scenic Biotech competitors
A few of Scenic Biotech's closest competitors — see the full list of competitors and alternatives →
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Circio Holding ASA is a biotechnology company that develops novel circular RNA and immunotherapy medicines, utilizing its proprietary circVec platform to enhance gene therapy for genetic diseases. It serves the biopharmaceutical sector and patients with genetic disorders by advancing clinical programs and engaging in research collaborations.
Skip Therapeutics is an Israeli biotechnology company founded in 2021 and based in Ness Ziona. The company develops personalized RNA-based therapies, including antisense oligonucleotides, for rare genetic disorders and common diseases using a proprietary computational discovery engine.
Shape Therapeutics, Inc. is a biotechnology research company founded in 2018 and headquartered in Seattle, Washington. The firm focuses on advancing the future of medicine through programmable RNA technologies and therapeutics.
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Iris Medicine is an early-stage life sciences and biotechnology company pioneering allele-selective RNA therapies. Headquartered in California, the company develops novel treatments utilizing its proprietary sbRNA technology platform.
Get Scenic Biotech's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Scenic Biotech in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access